MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-31-2025
Envista Holdings Corporation Market Cap 2011-2026 | NVST
As of January 30, 2026 Envista Holdings Corporation has a market cap of $ 3.97 B
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Envista Holdings Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.68 B | 3.75 B | 6.42 B | 7.74 B | 6.15 B | 4.25 B | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 7.74 B | 3.68 B | 5.33 B |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical instruments industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
639 M | - | - | $ 810 M |  USA |
 |
Baxter International
BAX
|
17.3 B | $ 19.93 | 0.99 % | $ 10.2 B | USA |
 |
Luminex Corporation
LMNX
|
1.27 B | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
809 K | - | -9.52 % | $ 20.6 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
727 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
2.27 B | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
152 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
6.07 B | - | -0.05 % | $ 10.3 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
15.6 B | - | -0.02 % | $ 16.3 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
9.68 M | $ 8.71 | 3.75 % | $ 176 M | USA |
 |
Alcon
ALC
|
42.6 B | $ 81.19 | 0.07 % | $ 40.4 B |  Schweiz |
 |
AtriCure
ATRC
|
1.91 B | $ 36.37 | -1.57 % | $ 1.71 B | USA |
 |
Repro Med Systems
KRMD
|
96.7 M | $ 5.37 | -1.56 % | $ 245 M | USA |
 |
Haemonetics Corporation
HAE
|
3.06 B | $ 65.87 | -0.15 % | $ 3.32 B | USA |
 |
electroCore
ECOR
|
29.4 K | $ 6.83 | -3.73 % | $ 37.7 K | USA |
 |
AngioDynamics
ANGO
|
355 M | $ 10.2 | 2.2 % | $ 417 M | USA |
 |
ICU Medical
ICUI
|
3.65 B | $ 149.04 | -0.66 % | $ 3.63 B | USA |
 |
InfuSystem Holdings
INFU
|
146 M | $ 8.14 | 1.12 % | $ 168 M | USA |
 |
The Cooper Companies
COO
|
16.3 B | $ 80.95 | 0.72 % | $ 16.1 B | USA |
 |
Masimo Corporation
MASI
|
8.96 B | $ 134.5 | -1.29 % | $ 7.17 B | USA |
 |
Harvard Bioscience
HBIO
|
188 M | $ 0.5 | -7.06 % | $ 21.2 M | USA |
 |
Glaukos Corporation
GKOS
|
4.3 B | $ 117.26 | -1.43 % | $ 5.68 B | USA |
 |
Merit Medical Systems
MMSI
|
5.94 B | $ 80.09 | -0.19 % | $ 4.66 B | USA |
 |
OraSure Technologies
OSUR
|
259 M | $ 2.78 | -0.54 % | $ 207 M | USA |
 |
Isoray
ISR
|
24.5 M | - | 0.03 % | $ 108 M | USA |
 |
iRhythm Technologies
IRTC
|
3.49 B | $ 150.09 | 0.74 % | $ 4.68 B | USA |
 |
LeMaitre Vascular
LMAT
|
2.07 B | $ 84.08 | 0.26 % | $ 1.89 B | USA |
 |
Intuitive Surgical
ISRG
|
203 B | $ 505.88 | -0.33 % | $ 180 B | USA |
 |
STERIS plc
STE
|
24.2 B | $ 261.25 | -0.23 % | $ 25.8 B | USA |
 |
NeuroMetrix
NURO
|
8.71 M | - | 5.05 % | $ 9.02 M | USA |
 |
Microbot Medical
MBOT
|
11.7 M | $ 1.84 | -1.34 % | $ 18.8 M |  Israel |
 |
Nephros
NEPH
|
22.5 M | $ 4.4 | 0.23 % | $ 45.7 M | USA |
 |
Utah Medical Products
UTMD
|
247 M | $ 60.16 | -2.42 % | $ 218 M | USA |
 |
Milestone Scientific
MLSS
|
69.4 M | $ 0.29 | -0.7 % | $ 23.1 M | USA |
 |
Pro-Dex
PDEX
|
150 M | $ 38.84 | -1.43 % | $ 128 M | USA |
 |
Predictive Oncology
POAI
|
8.29 M | - | - | $ 31.1 M | USA |
 |
Pulse Biosciences
PLSE
|
418 M | $ 13.69 | 0.48 % | $ 658 M | USA |
 |
Becton, Dickinson and Company
BDX
|
56.2 B | $ 201.67 | 0.29 % | $ 58 B | USA |
 |
Repligen Corporation
RGEN
|
10.8 M | $ 151.86 | -2.88 % | $ 8.46 M | USA |
 |
ResMed
RMD
|
35.1 B | $ 251.52 | -2.37 % | $ 36.7 B | USA |
 |
BioLife Solutions
BLFS
|
1.14 B | $ 22.08 | -2.21 % | $ 1.02 B | USA |
 |
Stereotaxis
STXS
|
215 M | $ 2.26 | -3.21 % | $ 182 M | USA |
 |
Retractable Technologies
RVP
|
21 M | $ 0.69 | 0.16 % | $ 20.7 M | USA |
 |
STAAR Surgical Company
STAA
|
832 M | $ 18.79 | -0.8 % | $ 923 M | USA |
 |
Teleflex Incorporated
TFX
|
6.21 B | $ 105.0 | -0.43 % | $ 4.92 B | USA |
 |
West Pharmaceutical Services
WST
|
15.4 B | $ 226.43 | -2.61 % | $ 16.5 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
3.5 B | $ 12.28 | 0.04 % | $ 2.5 B | USA |